Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons - Wikidata - wikimedia - TriplyDB

Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons

Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons

http://www.wikidata.org/entity/Q37716166

about

Modeling congenital disease and inborn errors of development in Drosophila melanogaster Intra-abdominal myositis ossificans in an asymptomatic patient during closure of a Hartmann's colostomy.Radiographic characteristics of the hand and cervical spine in fibrodysplasia ossificans progressiva The Natural History of Flare-Ups in Fibrodysplasia Ossificans Progressiva (FOP): A Comprehensive Global Assessment.Clinical and molecular characterisation of two siblings with fibrodysplasia ossificans progressiva, from the Colombian Pacific coast (South America).Clinical Utility Gene Card for: Fibrodysplasia ossificans progressiva.Granting immunity to FOP and catching heterotopic ossification in the Act.The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.Osteoblast Differentiation and Bone Matrix Formation In Vivo and In Vitro.Unsupervised Exercise-Induced Myositis Ossificans in the Brachialis Muscle of a Young Healthy Male: A Case Report.Phenotypic and Genotypic Characterization and Treatment of a Cohort With Familial Tumoral Calcinosis/Hyperostosis-Hyperphosphatemia Syndrome.Supraspinatus Intramuscular Calcified Hematoma or Necrosis Associated with Tendon Tear.Heterotopic ossification (myositis ossificans progressiva): A condition interfering with rheumatic disease Inhibition of overactive TGF-β attenuates progression of heterotopic ossification in mice.Stem cells and heterotopic ossification: Lessons from animal models.Multi-system involvement in a severe variant of fibrodysplasia ossificans progressiva (ACVR1 c.772G>A; R258G): A report of two patients.Difficult diagnosis and genetic analysis of fibrodysplasia ossificans progressiva: a case report.Flare-Up After Maxillofacial Surgery in a Patient With Fibrodysplasia Ossificans Progressiva: An [F]-NaF PET/CT Study and a Systematic Review

P2860

Q26765017-BB6A2498-634F-45DC-B47E-B2D8FE74BCCF Q30367815-D0D81292-C69F-4BAF-85B3-D06470E004ED Q34377748-AFD9EA2B-E331-48B7-BCFE-71469FE7370E Q34520201-8ACC8939-CAF6-4461-A0B4-E22449994A06 Q35699674-0D1C467D-3D19-48FD-B911-DF1CA482D4C6 Q36116661-7B0B5C00-452A-4BA0-A750-15A5014B2FF9 Q36981608-835E285A-8FED-4EC7-90B6-879BAE36AED2 Q37427265-A49A2D4C-46E5-46E5-8AF0-60E756756B30 Q39009479-8EB41801-D7C7-4B14-87A8-59E721B41F8F Q41105350-ACF19557-5A61-4899-AFD8-5286D6C4D696 Q41646281-09D22719-13D8-431E-84D1-F4D23AC26519 Q41814347-599C652C-2210-4DE8-8C64-FE819CDE0542 Q42318620-ED963854-7BEB-4557-AB8A-505C1405A6F4 Q49702140-80A8F701-A267-4EFA-A314-A943A75CE95F Q50152313-D4364E75-8B44-4422-A16C-203555A2950B Q53459641-8499D56D-288F-4853-B009-14F75E272BA6 Q54983398-2C7FF9FA-4D52-41E9-8996-9387AD53A513 Q57152952-1FDFBF9B-4A32-49D7-B23B-BEA8627E41BD

P2860

Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons

http://www.wikidata.org/entity/Q37716166

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons

@en

Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons.

@nl

type

label

Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons

@en

Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons.

@nl

prefLabel

Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons

@en

Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons.

@nl

P1433

Q37716166-A3A2F659-EE22-4911-94E5-6C13D8BE9ACF

P1476

Q37716166-1FC4130D-EFD5-4516-85A6-D26C9C1A52C6

P2093

Q37716166-2C97571C-CF3E-4461-B3C1-053568BAC530

Q37716166-8AFEF6B7-69D3-4B9C-B992-9ABE5997BC51

Q37716166-A8046149-55C8-4977-89A2-F97FB4B187F6

P2860

Q37716166-01B00E97-F53C-4F34-A9B5-1E3CE577A8D6

Q37716166-050631B0-E3B2-43C1-87E0-5D818BA0F9B8

Q37716166-05E0C903-86F0-4C4E-B34B-7A4AB00F2780

Q37716166-06CA9656-08F3-49EF-B047-E127DEF4728D

Q37716166-0D86181A-5200-457C-9380-9E2DA0B0CC7B

Q37716166-0DEACC65-6EC9-42B2-8F3A-6FB5E0FDDCBB

Q37716166-122B4CF2-989F-4E95-8DA0-6AC5A695DE05

Q37716166-1A385BC3-6EB9-4AB7-8314-35B84E26EC8F

Q37716166-20B24535-A01D-4C2A-88D0-14B87B31BB87

Q37716166-241018E2-DA54-43B9-A0EE-135E886D7A32

P304

Q37716166-BC16205D-F4BF-4934-8FBF-3AC1A5D25264

P31

Q37716166-C8B34E9C-F126-416A-B894-88BE4499AAFB

P478

Q37716166-2597B84D-CC31-411D-9943-E38718104A7D

P577

Q37716166-7A736C65-F4F1-4A62-89C5-0E72796274AB

P698

Q37716166-DC68CFD6-AAC3-4B7F-8CAD-B22A85D2C87C

P921

Q37716166-6caf8f85-91af-44e6-a4eb-c30a890c3a10

Q37716166-7A72B12E-2517-4EB7-ACB1-AB1C97272145

P932

Q37716166-890DC3A5-C83A-4077-BE5E-BD3A98982964

P1433

Pediatric Endocrinology Reviews

P1476

Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons

@en

P2093

Eileen M Shore

http://www.w3.org/2001/XMLSchema#string

Frederick S Kaplan

http://www.w3.org/2001/XMLSchema#string

Robert J Pignolo

http://www.w3.org/2001/XMLSchema#string

P2860

A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva

FKBP12 functions as an adaptor of the Smad7-Smurf1 complex on activin type I receptor

BMP type I receptor inhibition reduces heterotopic [corrected] ossification

Transgenic mice overexpressing BMP4 develop a fibrodysplasia ossificans progressiva (FOP)-like phenotype

ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation

Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements.

Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1

Identification of progenitor cells that contribute to heterotopic skeletogenesis

Substance P signaling mediates BMP-dependent heterotopic ossification

Applications of small molecule BMP inhibitors in physiology and disease.

P304

437-448

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P478

10 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23858627

http://www.w3.org/2001/XMLSchema#string

P921

fibrodysplasia ossificans progressiva

P932

3995352

http://www.w3.org/2001/XMLSchema#string